10 Oct 2025 | 5 Mins Read
Pharmova to invest $300 million in US by FY28, doubling capacity
Flipitmoney
Jubilant Pharmova's US arm, HollisterStier LLC, will invest $300 million by FY28 to double its sterile injectable manufacturing capacity, with a new line launched in Washington costing $132 million. The capacity will increase by 100% to produce 100 million vials annually, addressing a 700 million-unit demand-supply gap in the US sterile vials market primarily driven by US customers' demands.